DOAJ Open Access 2016

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS

S Yu Vorotnikova E A Pigarova

Abstrak

The data from a number of clinical trials investigating a once-yearly infusion of5 mg zoledronic acidshow a marked efficacy of this intervention in the treatment of primary and secondary osteoporosis with a combination of fracture risk reduction and prevention of bone loss at key skeletal sites. Recent research studies demonstrate beneficial features of original and generic zoledronic acid for treatment of patients with osteogenesis imperfecta, primary hyperparathyroidism, Paget’s disease of bone,vertebroplasty and dental implantation.

Topik & Kata Kunci

Osteopathy

Penulis (2)

S Yu Vorotnikova

E A Pigarova

Format Sitasi

APA MLA BibTeX

Vorotnikova, S.Y., Pigarova, E.A. (2016). ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS. https://doi.org/10.14341/osteo2016323-27

Akses Cepat

PDF tidak tersedia langsung

Cek di sumber asli →

Lihat di Sumber doi.org/10.14341/osteo2016323-27

Informasi Jurnal

Tahun Terbit: 2016
Sumber Database: DOAJ
DOI: 10.14341/osteo2016323-27
Akses: Open Access ✓